Controlled Substances Reporting (CSR)

Account Creation and Access

To create an account on the CSR platform, please do the following:

  1. You must create an account by going to the Controlled Substance Reporting System login here.
  2. After creating your account, the Division must confirm your role as an authorized reporter for your company. You may confirm your authorization status by submitting a confirmation letter signed by a corporate officer of your company. The confirmation letter should be submitted on company letterhead and should include the Company’s Drug Enforcement Administration (DEA) license number, DBPR license number and a statement that the company has authorized you to submit and review controlled substance reporting information on behalf of the company. If your company is a third-party agent who reports on behalf of another company, the confirmation letter must include the name, DEA license and DBPR license number for all companies on whose behalf your company will be reporting, in addition to the information listed above. (You will receive an email with this information as well).

To access the system, please do the following:

  1. Review the user guide linked here for assistance on how to navigate the new system and on how to submit reports to the platform.
  2. Login by entering your username and temporary password provided in the DBPR introductory email you will receive upon creating an account.
  3. Upon successfully logging in, you will be prompted to create your own unique password.
  4. You will use this username and your new password every time you login to the CSR platform. Passwords expire every 90 days; therefore, you need to create a new one every 90 days.

If you have any questions, you may contact us by phone 850-717-1800 or email us at CSRHelp@myfloridalicense.com.

General Requirements

These reports must be filed electronically with DBPR by the 20th day of the month following the month of the distribution of the controlled substance. Example: controlled substance distribution information for the month of September should have been reported no later than October 20.

FTP Reporting Process

The CSR platform can accept File Transfer Protocol (FTP) report processing. Please contact us at CSRhelp@myfloridalicense.com for FTP report processing instructions.

1. How do we register with CSR?

Review the “Information to Establish a CSR Account” section of the CSR User Guide.

2. What substances do we have to report?

Florida law requires reporting of all controlled substance distributions, Schedules II through V, inclusive.  This differs significantly from DEA’s ARCOS reporting requirements.  Florida’s schedules are set forth in Section 893.03, Florida Statutes.

3. How do we report, and what format do we use?

The report must be electronic and in the same format used for controlled substance reporting to ARCOS.  For more detailed information, review the CSR User Guide.

4. My company was not aware that we were required to register with CSR and begin reporting. What do we do?

Section 499.0121(14), Florida Statutes does not provide for any grace period.  Your company should register with CSR immediately, and submit all required distribution data from July 1, 2011 to the present.  The department reserves all rights with respect to CSR noncompliance.

5. Our company is supposed to be registered with CSR and submitting reports. What happens if we do not comply?

Failure to comply with CSR requirements could result in (i) denial, refusal to renew, revocation, or suspension of any permit or certification issued to the offender under the Florida Drug and Cosmetic Act; (ii) emergency suspension of or restriction on such a permit or certification; (iii) a cease and desist order; (iv) civil action for injunctive relief; (v) fine assessment in an amount not to exceed $5,000 – per violation, per day; (vi) any other action or relief provided by law; or (vii) some combination of the foregoing.

In addition to any other consequences, a knowing failure to report (or a knowing submission of false information to CSR) is a third-degree felony punishable as provided under Sections 775.082, 775.083 or 775.084, Florida Statutes, plus a criminal fine in an amount not to exceed three times the gross profits on the transaction(s), and payment of court costs and the reasonable costs of investigation and prosecution.

6. We experienced errors or failures with our CSR submission in a past month, or inadvertently provided incorrect information. What do we do?

CSR supports revisions to previous reports to clear errors and inaccuracies, and submission of historical data to bring your company’s reporting history up to date.  Review the appropriate sections of the CSR User Guide for further information.

7. My company just obtained one of the permit types affected by CSR, but was in the controlled substance business after July 1, 2011 under another, unaffected license type. Do we need to report those transactions?

No.  Register with CSR under the new, affected permit, and report all Florida controlled substance transactions after receiving the new permit.

8. My company already submits ARCOS data. Can I just report the Florida-specific portions to CSR?

Probably not.  DEA has unique reporting criteria and requirements, and the substantive controlled substance schedules are different.  More importantly, Florida law requires reporting of all controlled substance distributions, Schedules II through V, inclusive.  This differs significantly from DEA’s ARCOS reporting requirements.  Florida’s schedules are set forth in Section 893.03, Florida Statutes.

9. My company currently submits ARCOS reports to DEA on a schedule other than monthly. Can I do the same with Florida’s CSR?

No.  Florida law requires monthly reporting.

10. My company is registered with CSR, but we did not do any controlled substance business in Florida last month. Do I still have to submit a monthly report?

Yes.  If no controlled substance distributions occurred during a given month, a report to that effect must still be submitted.

11. I am a doctor, pharmacist or other health care practitioner who prescribes or dispenses controlled substances. Do I need to report to CSR?

Probably not, unless you are distributing (selling, transferring, delivering, shipping, etc.) controlled substances to someone other than a patient or consumer.  If you are only prescribing and dispensing prescriptions for controlled substances to patients or consumers, then you may need to register with and report to E-FORCSE.

Note:  Community Pharmacies also holding a Retail Pharmacy Drug Wholesale Distributor permit may need to register with and report to both CSR and E-FORCSE.  See FAQ #1 for more information.

12. What is the difference between E-FORCSE and CSR?

E-FORCSE collects information about retail controlled substance transactions such as prescribing by a physician or dispensing by a pharmacist.  CSR collects information about wholesale transactions such as shipments to pharmacies.  E-FORCSE is maintained and operated by a different agency, the Florida Department of Health.  For more information visit the E-FORCSE homepage at http://www.floridahealth.gov/reports-and-data/e-forcse/index.html.

NOTICE: You are now leaving the DBPR Internet website. DBPR is not responsible for the content of the Internet website you are entering. DBPR neither warrants nor makes any representations nor endorsements as to the accuracy, quality, content or completeness of the information, text, images, graphics, hyperlinks and other items contained on the Internet website you are entering. DBPR is not responsible or liable for any viruses or contaminations of your hardware, software, peripherals or property, resulting from use of Internet websites linked to or from the DBPR Internet website.

Need Help?

All requests for publications, documents, forms, applications for licenses, permits and other similar certifications can be obtained by contacting the Customer Contact Center.

Anthony Coniglio, Director

Division of Drugs, Devices and Cosmetics
2601 Blair Stone Road
Tallahassee, FL 32399-1047

Telephone: 850.717.1800